Van de Wal H, Arkenbout P, Ten Berge E, Jongerius C, Debruyne F, Lacquet L
Acta Chir Belg. 1984 Nov-Dec;84(6):349-56.
Before the era of chemotherapy an extensively metastasized non-seminomatous testicular tumour was nearly always fatal. Only 10 cases of spontaneous regression of thoracic metastasis have been reported. With chemotherapy, a much better outlook has been achieved, however, in 10% of the cases, chemotherapy resistant thoracic masses remain after treatment. In 70 to 80% of those cases with normal tumour markers, mature teratoma is found. In this paper, three patients with non-seminomatous testicular tumour and thoracic opacities resistant to conservative treatment are reported. One patient showed a complete disappearance of 9 out of 10 thoracic opacities 6 months after a short chemotherapy course, which had seemed to be ineffective. After a short period of reduction, the remaining opacity demonstrated continued tumour growth with a significantly longer tumour doubling time. The other two patients showed enlarged thoracic opacities despite combination chemotherapy and normal tumour marker levels. At the time of thoracotomy and complete surgical resection of the tumours all patients had normal tumour marker levels. Mature teratoma without genuine malignant cells was found microscopically. At this time all patients are free of metastases, 18, 3.5 and 2 year post thoracotomy. We suggest complete extirpation of the chemotherapy resistant lesions because, mature teratoma may give rise to compression and because in the cases with notwithstanding normalization of tumour markers and active tumour histology has to be obtained to restart combination chemotherapy.
在化疗时代之前,广泛转移的非精原细胞瘤性睾丸肿瘤几乎总是致命的。仅报告了10例胸部转移灶自发消退的病例。有了化疗,预后有了很大改善,然而,10%的病例在治疗后仍存在对化疗耐药的胸部肿块。在那些肿瘤标志物正常的病例中,70%至80%发现为成熟畸胎瘤。本文报告了3例非精原细胞瘤性睾丸肿瘤伴胸部不透明影且对保守治疗耐药的患者。1例患者在短期化疗疗程后6个月,10个胸部不透明影中有9个完全消失,而该疗程起初似乎无效。经过短暂缩小后,剩余的不透明影显示肿瘤持续生长,肿瘤倍增时间明显延长。另外2例患者尽管接受了联合化疗且肿瘤标志物水平正常,但胸部不透明影仍增大。在开胸手术并完全切除肿瘤时,所有患者的肿瘤标志物水平均正常。显微镜下发现为无真正恶性细胞的成熟畸胎瘤。此时,所有患者在开胸手术后18年、3.5年和2年都没有转移。我们建议彻底切除对化疗耐药的病灶,因为成熟畸胎瘤可能会引起压迫,而且在肿瘤标志物正常的情况下,必须获取活跃的肿瘤组织学结果才能重新开始联合化疗。